Dapsone

Dapsone

SCHEMBL2203636

N.N.Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP1

The experimentally established mechanism targets of Dapsone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.94
TSHR P16473 3/20 0.94
CYP3A4 P08684 2/20 0.94
LMNA P02545 2/20 0.94
MPO P05164 1/20 0.94
CYP2C9 P11712 1/20 0.94
MEN1 O00255 1/20 0.73
KMT2A Q03164 1/20 0.73
ALDH1A1 P00352 3/20 0.67
PKM P14618 2/20 0.67
CA1 P00915 3/20 0.62
CA2 P00918 3/20 0.62
CA12 O43570 2/20 0.62
CA9 Q16790 2/20 0.62
CA14 Q9ULX7 2/20 0.62
AGO2 Q9UKV8 2/20 0.62
USP2 O75604 1/20 0.62
CA4 P22748 1/20 0.62
CA6 P23280 1/20 0.62
CA5A P35218 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dapsone SCHEMBL27664082 1.00 HTR6 (0.94) HTR6TSHRCYP3A4LMNAMPO
SCHEMBL324893 0.97 HTR6 (1.00) HTR6TSHRCYP3A4LMNAMPO
SCHEMBL10596934 0.97 HTR6 (1.00) HTR6TSHRCYP3A4LMNAMPO
Dapsone SCHEMBL21428 0.97 HTR6 (1.00) HTR6TSHRCYP3A4LMNAMPO
Dapsone SCHEMBL1219599 0.97 HTR6 (1.00) HTR6TSHRCYP3A4LMNAMPO
Dapsone SCHEMBL5055312 0.97 HTR6 (1.00) HTR6TSHRCYP3A4LMNAMPO
Dapsone SCHEMBL9690505 0.94 HTR6 (0.94) HTR6TSHRCYP3A4LMNAMPO
Dapsone SCHEMBL11745790 0.94 HTR6 (0.94) HTR6TSHRCYP3A4LMNAMPO
Dapsone SCHEMBL9690514 0.94 HTR6 (0.94) HTR6TSHRCYP3A4LMNAMPO
Dapsone SCHEMBL28520980 0.94 HTR6 (0.94) HTR6TSHRCYP3A4LMNAMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1022301-B1 Essentially colorless, transparent polyimide coatings and films IST CORP (US) 2004-04-28 EP claimed
EP-0593200-B1 Method for preparing polyimides GEN ELECTRIC (US) 1997-05-28 EP claimed
WO-2014031923-A1 COATED SUBSTRATES AND METHODS FOR PRODUCING THE SAME MILLIKEN & COMPANY (US) 2014-02-27 WO disclosed
US-20140058026-A1 COATED SUBSTRATES AND METHODS FOR PRODUCING THE SAME MILLIKEN & COMPANY (US) 2014-02-27 US disclosed
US-7981996-B2 reaction of a diamine such as ortho, meta or para-phenylenediamine with an anhydride like 3- or 4-chlorophthalic anhydride (3-ClPA) in the presence of a solvent (ortho dichlorobenzene) at a temperature above the normal boiling point of the solvent to produce bis/halophthalobisimide/; limited solubility SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2011-07-19 US disclosed
US-20080119660-A1 reaction of a diamine such as ortho, meta or para-phenylenediamine with an anhydride like 3- or 4-chlorophthalic anhydride (3-ClPA) in the presence of a solvent (ortho dichlorobenzene) at a temperature above the normal boiling point of the solvent to produce bis/halophthalobisimide/; limited solubility GENERAL ELECTRIC COMPANY (US) 2008-05-22 US disclosed
US-5969079-A HEAT RESISTANT, HIGH STRENGTH AEROSPACE ENGINEERING THERMOPLASTICS THE BOEING COMPANY (US) 1999-10-19 US disclosed
US-5756597-A COMPOSITE; MIXTURE WITH A COMPATIBLE POLYMER THE BOEING COMPANY (US) 1998-05-26 US disclosed
US-5714566-A CONDENSING DIAMINOPHENOL WITH LINEAR OR MULTIDIMENSIONAL INTERMEDIATE TO FORM BISAMINE, CONDENSING WITH ACID HALIDE THE BOEING COMPANY (US) 1998-02-03 US disclosed
US-5610317-A CHEMICAL AND THERMAL PROPERTIES THE BOEING COMPANY (US) 1997-03-11 US disclosed
EP-0286214-A2 Novel oligomeric diamine hardeners and their use for curing epoxy resin systems AMOCO CORPORATION (US) 1988-10-12 EP disclosed
US-4746718-A Novel oligomeric diamine hardeners and their use for curing epoxy resin systems AMOCO CORPORATION (US) 1988-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119660-A1 reaction of a diamine such as ortho, meta or para-phenylenediamine with an anhydride like 3- or 4-chlorophthalic anhydride (3-ClPA) in the presence of a solvent (ortho dichlorobenzene) at a temperature above the normal boiling point of the solvent to produce bis/halophthalobisimide/; limited solubility DDT, DDC, DDAH1 HTR6 1592/4885TSHR 4136/4885CYP3A4 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.